Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Esquire Financial | ESQ | Sep 23, 2024 | 63.31 | +0.35 |
ESS Tech | GWH | Sep 23, 2024 | 5.79 | +2.84 |
ESSA Bancorp | ESSA | Sep 23, 2024 | 18.71 | +0.54 |
ESSA Pharma | EPIX | Sep 23, 2024 | 6.43 | -0.46 |
Essent Group | ESNT | Sep 23, 2024 | 64.20 | +1.07 |
Essential Properties Realty Trust | EPRT | Sep 23, 2024 | 34.49 | +1.14 |
Essential Utilities | WTRG | Sep 23, 2024 | 38.29 | +0.76 |
Essex Property Trust | ESS | Sep 23, 2024 | 309.65 | +1.12 |
Establishment Labs | ESTA | Sep 23, 2024 | 40.13 | -5.47 |
Estee Lauder Companies | EL | Sep 23, 2024 | 86.70 | +1.99 |
Estrella Immunopharma | ESLA | Sep 23, 2024 | 0.97 | -3.96 |
Eterna Therapeutics | ERNA | Sep 23, 2024 | 1.22 | -4.69 |
ETFMG Alternative Harvest ETF | MJ | Sep 23, 2024 | 3.31 | +1.85 |
Ethan Allen Interiors | ETD | Sep 23, 2024 | 31.16 | -2.14 |
Eton Pharmaceuticals | ETON | Sep 23, 2024 | 5.83 | +7.56 |
Etsy | ETSY | Sep 23, 2024 | 54.83 | +1.71 |
Euda Health | EUDA | Sep 23, 2024 | 3.78 | +5.00 |
Eupraxia Pharmaceuticals | EPRX | Sep 23, 2024 | 2.81 | -2.23 |
Eureka Acquisition | EURK | Sep 23, 2024 | 10.04 | 0.00 |
Eureka Acquisition | EURKU | Sep 23, 2024 | 10.65 | 0.00 |
Euro Tech Holdings | CLWT | Sep 23, 2024 | 1.64 | 0.00 |
Euro Trust | FXE | Sep 23, 2024 | 102.67 | -0.42 |
EuroDry | EDRY | Sep 23, 2024 | 20.40 | -0.49 |
Euronav | CMBT | Sep 23, 2024 | 15.86 | 0.00 |
Euronav | EURN | Sep 23, 2024 | 16.31 | 0.00 |
Euronet Worldwide | EEFT | Sep 23, 2024 | 102.22 | +1.55 |
Europe Alphadex First Trust | FEP | Sep 23, 2024 | 38.86 | -0.19 |
Europe ETF FTSE Vanguard | VGK | Sep 23, 2024 | 70.03 | +0.32 |
Europe Financials Index MSCI Ishares | EUFN | Sep 23, 2024 | 24.50 | -0.28 |
Europe Smallcap Dividend Wisdomtree | DFE | Sep 23, 2024 | 62.95 | +0.35 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.